Enanta Pharmaceuticals, Inc. (ENTA)

Enanta Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019
Cash & Equivalents	35.78	85.39	43.99	57.21	87.13	51.23
Short-Term Investments	194.31	284.52	205.24	186.8	299.52	284.01
Cash & Short-Term Investments	230.09	369.91	249.23	244	386.65	335.24
Cash Growth	-40.48%	48.42%	2.14%	-36.89%	15.34%	8.59%
Accounts Receivable	8.18	8.61	20.32	23.58	23.49	51.31
Other Receivables	32.46	31	28.72	37.26	13.04	-
Receivables	40.63	39.62	49.04	60.83	36.53	51.31
Prepaid Expenses	15.26	13.26	13.45	14.19	13.66	15.3
Total Current Assets	286.58	422.79	311.71	319.02	436.84	401.85
Property, Plant & Equipment	66.26	34.71	29.75	10.65	15.62	10.93
Long-Term Investments	42.51	-	29.29	108.42	32.63	65.01
Long-Term Deferred Tax Assets	-	-	-	-	0.35	11.34
Other Long-Term Assets	3.47	4.77	4.66	0.7	0.7	0.7
Total Assets	398.82	462.28	375.41	438.79	486.13	489.83
Accounts Payable	10.68	4.1	6	9.54	5.74	6.69
Accrued Expenses	12.83	18.34	20.94	22.43	14.16	15.83
Current Portion of Long-Term Debt	32.3	35.08	-	-	-	-
Current Portion of Leases	2.43	5.28	2.89	4.2	4.26	0.09
Total Current Liabilities	58.23	62.79	29.83	36.17	24.16	22.61
Long-Term Debt	143.31	160.85	1.42	1.51	1.48	1.63
Long-Term Leases	48.14	21.24	22.37	1.13	3.84	0.2
Other Long-Term Liabilities	0.23	0.66	0.45	0.56	1.08	2.9
Total Liabilities	249.91	245.54	54.08	39.36	30.55	27.34
Common Stock	0.21	0.21	0.21	0.2	0.2	0.2
Additional Paid-In Capital	443.57	424.69	398.03	351.03	326.96	298.41
Retained Earnings	-294.22	-207	-73.18	48.58	127.57	163.74
Comprehensive Income & Other	-0.65	-1.17	-3.72	-0.38	0.84	0.15
Shareholders' Equity	148.92	216.74	321.33	399.43	455.58	462.49
Total Liabilities & Equity	398.82	462.28	375.41	438.79	486.13	489.83
Total Debt	226.17	222.44	26.69	6.84	9.58	1.92
Net Cash (Debt)	46.42	147.47	251.83	345.58	409.71	398.33
Net Cash Growth	-71.29%	-41.44%	-27.13%	-15.65%	2.86%	23.28%
Net Cash Per Share	2.20	7.03	12.22	17.13	20.55	19.00
Filing Date Shares Outstanding	21.19	21.06	20.8	20.32	20.08	19.73
Total Common Shares Outstanding	21.18	21.06	20.79	20.24	20.08	19.7
Working Capital	228.35	360	281.89	282.85	412.68	379.24
Book Value Per Share	7.03	10.29	15.46	19.74	22.69	23.47
Tangible Book Value	148.92	216.74	321.33	399.43	455.58	462.49
Tangible Book Value Per Share	7.03	10.29	15.46	19.74	22.69	23.47
Machinery	20.05	19.14	16.79	16.32	15.82	15.19
Construction In Progress	14.8	1.27	2.56	0.02	-	-
Leasehold Improvements	13.98	13.8	7.28	7.14	7.09	6.62

Source: S&P Capital IQ. Standard template. Financial Sources.